Pasithea Therapeutics (KTTA) Exchange Rate Effect (2021 - 2026)
Pasithea Therapeutics (KTTA) posted Exchange Rate Effect of $28132.0 for Q1 2026, up 5949.89% sequentially from $465.0 in Q4 2025.
Pasithea Therapeutics (KTTA) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Pasithea Therapeutics has reported Exchange Rate Effect for 6 years, with the latest figure at $28132.0 in Q1 2026.
- Quarterly Exchange Rate Effect changed N/A year-over-year to $28132.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69413.0 (changed N/A YoY) and the FY2025 annual result came in at $18766.0, up 844.98% from the prior year.
- Exchange Rate Effect climbed to $28132.0 in Q1 2026 per KTTA's latest filing, from $465.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $139421.0 in Q4 2022 and troughed at -$82515.0 in Q3 2022.
- A 5-year average of $2977.1 and a median of -$620.0 in 2024 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 2150.61% in 2022, down 5590.69% in 2022.
- Over 5 years, Exchange Rate Effect stood at $139421.0 in 2022, then slumped by 97.8% to $3065.0 in 2023, then surged by 818.3% to $28146.0 in 2024, then slumped by 98.35% to $465.0 in 2025, then soared by 5949.89% to $28132.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $28132.0, $465.0, and $12670.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | - |
| 10 | Pasithea Therapeutics | 16.62 Mn | 16.62 Mn | - | -37,328.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,132.00 |
| Mar 31, 2026 | 28,132.00 |
| Dec 31, 2025 | 465.00 |
| Dec 31, 2025 | 465.00 |
| Sep 30, 2025 | 12,670.00 |
| Sep 30, 2025 | 12,670.00 |
| Dec 31, 2024 | 28,146.00 |
| Dec 31, 2024 | 28,146.00 |
| Sep 30, 2024 | -27,133.00 |
| Sep 30, 2024 | -27,133.00 |
| Jun 30, 2024 | -2,912.00 |
| Jun 30, 2024 | -2,912.00 |
| Mar 31, 2024 | -620.00 |
| Mar 31, 2024 | -620.00 |
| Dec 31, 2023 | 3,065.00 |
| Dec 31, 2023 | 3,065.00 |
| Sep 30, 2023 | -4,256.00 |
| Sep 30, 2023 | -4,256.00 |
| Jun 30, 2023 | -317.00 |
| Jun 30, 2023 | -317.00 |